- Home
- BOTJ vs CLSD Comparison
BOTJ vs CLSD Comparison
Compare BOTJ & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- CLSD
- Stock Information
- Founded
- BOTJ 1998
- CLSD 2011
- Country
- BOTJ United States
- CLSD United States
- Employees
- BOTJ N/A
- CLSD N/A
- Industry
- BOTJ Major Banks
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- BOTJ Finance
- CLSD Health Care
- Exchange
- BOTJ Nasdaq
- CLSD Nasdaq
- Market Cap
- BOTJ 62.8M
- CLSD 68.6M
- IPO Year
- BOTJ N/A
- CLSD 2016
- Fundamental
- Price
- BOTJ $14.50
- CLSD $0.90
- Analyst Decision
- BOTJ
- CLSD Strong Buy
- Analyst Count
- BOTJ 0
- CLSD 5
- Target Price
- BOTJ N/A
- CLSD $5.20
- AVG Volume (30 Days)
- BOTJ 2.3K
- CLSD 103.8K
- Earning Date
- BOTJ 04-30-2025
- CLSD 05-14-2025
- Dividend Yield
- BOTJ 2.76%
- CLSD N/A
- EPS Growth
- BOTJ N/A
- CLSD N/A
- EPS
- BOTJ 1.45
- CLSD N/A
- Revenue
- BOTJ $45,083,000.00
- CLSD $1,664,000.00
- Revenue This Year
- BOTJ N/A
- CLSD N/A
- Revenue Next Year
- BOTJ N/A
- CLSD $675.15
- P/E Ratio
- BOTJ $9.81
- CLSD N/A
- Revenue Growth
- BOTJ 4.72
- CLSD N/A
- 52 Week Low
- BOTJ $10.14
- CLSD $0.70
- 52 Week High
- BOTJ $17.05
- CLSD $1.65
- Technical
- Relative Strength Index (RSI)
- BOTJ 60.84
- CLSD 56.82
- Support Level
- BOTJ $14.00
- CLSD $0.81
- Resistance Level
- BOTJ $14.40
- CLSD $0.92
- Average True Range (ATR)
- BOTJ 0.34
- CLSD 0.06
- MACD
- BOTJ 0.07
- CLSD 0.01
- Stochastic Oscillator
- BOTJ 86.21
- CLSD 83.17
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.